Post-operative outcomes of Pituitary Macroadenoma Patients in a Tertiary Hospital in the Philippines
DOI:
https://doi.org/10.15605/jafes.040.02.14Keywords:
pituitary macroadenoma, pituitary surgery, post-operative outcomes, PhilippinesAbstract
Background. Pituitary adenomas comprise approximately 20% of surgically resected intracranial tumors. This study aimed to collect local data on the post-operative neurologic, visual and endocrine outcomes of patients with pituitary macroadenoma.
Methodology. This is a retrospective study of patients with pituitary macroadenoma who underwent neurosurgery at the Philippine General Hospital between 2017 to 2022. Data on demographics, clinical signs and symptoms, neuro-ophthalmologic examination findings, hormonal and radiologic studies, type of surgery, and post-operative outcomes were collected. Statistical analyses were done to compare the neurologic, ophthalmologic and endocrine status pre- and post-operatively.
Results. A total of 122 patients were included. The mean age was 44.18 years, and majority (50.82%) were female. The most common presentation was blurring of vision. Most tumors were non-functioning (77.87%). Among the functioning adenomas, the most common was acromegaly. The median tumor size was 3.5 cm, and the median time to surgery was 18 months. Microscopic transsphenoidal surgery was the most common approach (60.83%) followed by endoscopic resection (24.17%). There was significant improvement in visual acuity post-operatively (p >0.05), by approximately one line in the Snellen chart. There was also some improvement in post-operative endocrine function, manifested as a significant decrease in the use of hormone replacement therapy. Factors such as age, sex, type of adenoma, tumor size, timing of surgery, surgical approach, post-operative complications and adjuvant radiation were not significantly associated with the visual and endocrine outcomes (p >0.005).
Conclusion. This is the first local study to comprehensively assess the entirety of post-operative outcomes among pituitary macroadenoma patients. Our results showed that even patients with longstanding visual and endocrine deficits may still improve with surgery.
Downloads
References
1. Winn HR, Youmans JR. Youmans neurological surgery, 8th ed. Philadelphia: WB Saunders, 2022.
2. Muskens IS, Zamanipoor Najafabadi AH, Briceno V, et al. Visual outcomes after endoscopic endonasal pituitary adenoma resection: A systematic review and meta-analysis. Pituitary. 2017:20(5);539-52. https://pubmed.ncbi.nlm.nih.gov/28643208 https://pmc.ncbi.nlm.nih.gov/articles/PMC5606952 https://doi.org/10.1007/s11102-017-0815-9 DOI: https://doi.org/10.1007/s11102-017-0815-9
3. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: A systematic review. Cancer. 2004;101(3);613-9. https://pubmed.ncbi.nlm.nih.gov/15274075 https://doi.org/10.1002/cncr.20412 DOI: https://doi.org/10.1002/cncr.20412
4. Ho RW, Huang HM, Ho JT. The influence of pituitary adenoma size on vision and visual outcomes after trans-sphenoidal adenectomy: A report of 78 cases. J Korean Neurosurg Soc. 2015;57(1);23-31. https://pubmed.ncbi.nlm.nih.gov/25674340 https://pmc.ncbi.nlm.nih.gov/articles/PMC4323501 https://doi.org/10.3340/jkns.2015.57.1.23 DOI: https://doi.org/10.3340/jkns.2015.57.1.23
5. Gupta P, Tripathi M, Dhandapani S, Dutta P. India's march towards development of treatment for pituitary tumors. Neurol India. 2020;68(5):1183-7. https://pubmed.ncbi.nlm.nih.gov/33109872 https://doi.org/10.4103/0028-3886.299156 DOI: https://doi.org/10.4103/0028-3886.299156
6. Kerrison JB, Lynn MJ, Baer CA, Newman SA, Biousse V, Newman NJ. Stages of improvement in visual fields after pituitary tumor resection. Am J Ophthalmol. 2000;130(6): 813-20. https://pubmed.ncbi.nlm.nih.gov/11124302 https://doi.org/10.1016/s0002-9394(00)00539-0 DOI: https://doi.org/10.1016/S0002-9394(00)00539-0
7. Müslüman AM, Cansever T, Yılmaz A, et al. Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes. World Neurosurg. 2011;76(1-2):141-8; discussion 63-6. https://pubmed.ncbi.nlm.nih.gov/21839965 https://doi.org/10.1016/j.wneu.2011.02.009 DOI: https://doi.org/10.1016/j.wneu.2011.02.009
8. Kanmounye US, Nguembu S, Djiofack D, et al. Patient attitudes toward neurosurgery in low- and middle-income countries: A systematic review. Neurol India. 2021;69(1):12-20. https://pubmed.ncbi.nlm.nih.gov/33642264 https://doi.org/10.4103/0028-3886.310098 DOI: https://doi.org/10.4103/0028-3886.310098
9. GBD 2019 Blindness and Vision Impairment Collaborators on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):E130-43. https://pubmed.ncbi.nlm.nih.gov/33275950 https://pmc.ncbi.nlm.nih.gov/articles/PMC7820390 https://doi.org/10.1016/S2214-109X(20)30425-3 DOI: https://doi.org/10.1016/S2214-109X(20)30425-3
10. de Vries F, Lobatto DJ, Verstegen MJT, van Furth WR, Pereira AM, Biermasz NR. Post-operative diabetes insipidus: How to define and grade this complication?. Pituitary. 2021;24(2):284-91. https://pubmed.ncbi.nlm.nih.gov/32990908 https://pmc.ncbi.nlm.nih.gov/articles/PMC7966184 https://doi.org/10.1007/s11102-020-01083-7 DOI: https://doi.org/10.1007/s11102-020-01083-7
11. Kourbeti IS, Jacobs AV, Koslow M, Karabetsos D, Holzman RS. Risk factors associated with postcraniotomy meningitis. Neurosurgery. 2007;60(2):317-25, discussion 325-6. https://pubmed.ncbi.nlm.nih.gov/17290182 https://doi.org/10.1227/01.NEU.0000249266.26322.25 DOI: https://doi.org/10.1227/01.NEU.0000249266.26322.25
12. Daniel WW, Cross CL. Biostatistics: A foundation for analysis in the health sciences, 10th ed. Hoboken: Wiley & Sons, Inc.; 2013.
13. Tabuzo MMB, Hernandez MALU, Chua AE, Maningat PD, Chiu HHC, Jamora RDG. Pituitary adenoma in the Philippines: A scoping review on the treatment gaps, challenges, and current state of care. Med Sci. 2024;12(1):16. https://pubmed.ncbi.nlm.nih.gov/38535157 https://pmc.ncbi.nlm.nih.gov/articles/PMC10972485 https://doi.org/10.3390/medsci12010016 DOI: https://doi.org/10.20944/preprints202401.1848.v1
14. Haizel-Cobbina J, Dada OE, Du L, Zuckerman SL, Dewan MC. A comparison of surgery wait times and post-operative length of hospital stay among patients with brain tumors by country-level income and healthcare system: A systematic review and meta-analysis. World Neurosurg. 2023;177:152-64.e13. https://pubmed.ncbi.nlm.nih.gov/37331477 https://doi.org/10.1016/j.wneu.2023.06.030 DOI: https://doi.org/10.1016/j.wneu.2023.06.030
15. Ferrante E, Ferraroni M, Castrignanò T, et al. Nonfunctioning pituitary adenoma database: A useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol . 2006;155(6):823-9. https://pubmed.ncbi.nlm.nih.gov/17132751 https://doi.org/10.1530/eje.1.02298 DOI: https://doi.org/10.1530/eje.1.02298
16. Tagoe NN, Essuman VA, Bankah P, et al. Visual outcome of patients with pituitary adenomas following surgery and its contributory factors at a tertiary hospital in Ghana. Ethiop J Health Sci. 2019;29(1):895-902. https://pubmed.ncbi.nlm.nih.gov/30700957 https://pmc.ncbi.nlm.nih.gov/articles/PMC6341437 https://doi.org/10.4314/ejhs.v29i1.11 DOI: https://doi.org/10.4314/ejhs.v29i1.11
17. Mbaye M, Mbaye T, Diedhiou D, et al. Management of pituitary adenoma: Preliminary experience with endoscopic endonasal transphenoidal surgery in a developing country. Example of Senegal about 180 cases. Interdiscip Neurosurg. 2024;36:101903. https://doi.org/10.1016/j.inat.2023.101903 DOI: https://doi.org/10.1016/j.inat.2023.101903
18. Sun M, Zhang ZQ, Ma CY, Chen SH, Chen XJ. Predictive factors of visual function recovery after pituitary adenoma resection: A literature review and meta-analysis. Int J Ophthalmol. 2017;10(11):1742-50. https://pubmed.ncbi.nlm.nih.gov/29181320 https://pmc.ncbi.nlm.nih.gov/articles/PMC5686375 https://doi.org/10.18240/ijo.2017.11.17 DOI: https://doi.org/10.18240/ijo.2017.11.17
19. Guo S,Wang Z, Kang X, Xin W, Li X. A meta-analysis of endoscopic vs. microscopic transsphenoidal surgery for non-functioning and functioning pituitary adenomas: Comparisons of efficacy and safety. Front Neurol. 2021;12:614382. https://pubmed.ncbi.nlm.nih.gov/33833725 https://pmc.ncbi.nlm.nih.gov/articles/PMC8021708 https://doi.org/10.3389/fneur.2021.614382 DOI: https://doi.org/10.3389/fneur.2021.614382
20. Feinsod M, Selhorst JB, Hoyt WF, Wilson CB. Monitoring optic nerve function during craniotomy. J Neurosurg. 1976;44(1):29-31. https://pubmed.ncbi.nlm.nih.gov/1244432 https://doi.org/10.3171/jns.1976.44.1.0029 DOI: https://doi.org/10.3171/jns.1976.44.1.0029
21. Glisson CC. Visual loss due to optic chiasm and retrochiasmal visual pathway lesions. Continuum (Minneap Minn). 2014;20(4 Neuro-ophthalmology):907-21. https://pubmed.ncbi.nlm.nih.gov/25099100 https://pmc.ncbi.nlm.nih.gov/articles/PMC10564022 https://doi.org/10.1212/01.CON.0000453312.37143.d2 DOI: https://doi.org/10.1212/01.CON.0000453312.37143.d2
22. Mackinnon SE. Pathophysiology of nerve compression. Hand Clin. 2002;18(2):231-41. https://pubmed.ncbi.nlm.nih.gov/12371026 https://doi.org/10.1016/s0749-0712(01)00012-9 DOI: https://doi.org/10.1016/S0749-0712(01)00012-9
23. Garcia T, Sanchez S, Litré CF, et al. Prognostic value of retinal nerve fiber layer thickness for postoperative peripheral visual field recovery in optic chiasm compression. J Neurosurg. 2014;121(1):165-9. https://pubmed.ncbi.nlm.nih.gov/24702324 https://doi.org/10.3171/2014.2.JNS131767 DOI: https://doi.org/10.3171/2014.2.JNS131767
24. Danesh-Meyer HV, Papchenko T, Savino PJ, Law A, Evans J, Gamble GD. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci. 2008;49(5):1879-85. https://pubmed.ncbi.nlm.nih.gov/18263812 https://doi.org/10.1167/iovs.07-1127 DOI: https://doi.org/10.1167/iovs.07-1127
25. Thotakura AK, Patibandla MR, Panigrahi MK, Addagada GC. Predictors of visual outcome with transsphenoidal excision of pituitary adenomas having suprasellar extension: A prospective series of 100 cases and brief review of the literature. Asian J Neurosurg. 2017;12(1):1-5. https://pubmed.ncbi.nlm.nih.gov/28413523 https://pmc.ncbi.nlm.nih.gov/articles/PMC5379778 https://doi.org/10.4103/1793-5482.149995 DOI: https://doi.org/10.4103/1793-5482.149995
26. Uy B, Wilson B, Kim WJ, Prashant G, Bergsneider M. Visual outcomes after pituitary surgery. Neurosurg Clin North Am. 2019;30(4):483-9. https://pubmed.ncbi.nlm.nih.gov/31471055 https://doi.org/10.1016/j.nec.2019.06.002 DOI: https://doi.org/10.1016/j.nec.2019.06.002
27. Moon CH, Hwang SC, Ohn YH, Park TK. The time course of visual field recovery and changes of retinal ganglion cells after optic chiasmal decompression. Invest Ophthalmol Vis Sci. 2011;52(11):7966-73. https://pubmed.ncbi.nlm.nih.gov/21896856 https://doi.org/10.1167/iovs.11-7450 DOI: https://doi.org/10.1167/iovs.11-7450
28. Villegas MQA, Quinto GM, Quimpo JA. A review of patients with pituitary tumors at St. Luke’s Medical Center from January 1997 to September 2000. Philipp J Intern Med. 2002;40(1):40-3.
29. Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017;8(3):33-48. https://pubmed.ncbi.nlm.nih.gov/28377801 https://pmc.ncbi.nlm.nih.gov/articles/PMC5363454 https://doi.org/10.1177/2042018816687240 DOI: https://doi.org/10.1177/2042018816687240
30. Jahangiri A, Wagner JR, Han SW, et al. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: Rate, time course, and radiological analysis. J Neurosurg. 2016;124(3):589-95. https://pubmed.ncbi.nlm.nih.gov/26252454 https://doi.org/10.3171/2015.1.JNS141543 DOI: https://doi.org/10.3171/2015.1.JNS141543
31. Webb SM, Rigla M, Wägner A, Oliver B, Bartumeus F. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab. 1999;84(10):3696-700. https://pubmed.ncbi.nlm.nih.gov/10523016 https://doi.org/10.1210/jcem.84.10.6019 DOI: https://doi.org/10.1210/jcem.84.10.6019
32. Fatemi N, Dusick JR, Mattozo C, et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery. 2008;63(4):709-18. https://pubmed.ncbi.nlm.nih.gov/18981881 https://doi.org/10.1227/01.NEU.0000325725.77132.90 DOI: https://doi.org/10.1227/01.NEU.0000325725.77132.90
33. Mavromati M, Mavrakanas T, Jornayvaz FR, et al. The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas. Endocrine. 2023;81(2): 340-8. https://pubmed.ncbi.nlm.nih.gov/37222882 https://pmc.ncbi.nlm.nih.gov/articles/PMC10293445 https://doi.org/10.1007/s12020-023-03400-z DOI: https://doi.org/10.1007/s12020-023-03400-z
34. Fonte JS, Cunanan EC, Mercado-Asis LB, Matawaran BJ. Treatment outcomes of pituitary tumors at the University of Santo Tomas Hospital: 2004-2008. Philipp J Intern Med. 2009;47(3):121-8. DOI: https://doi.org/10.3860/pjim.v47i3.1654
35. Buttan A, Mamelak AN. Endocrine outcomes after pituitary surgery. Neurosurg Clin North Am. 2019;30(4):491-8. https://pubmed.ncbi.nlm.nih.gov/31471056 https://doi.org/10.1016/j.nec.2019.05.009 DOI: https://doi.org/10.1016/j.nec.2019.05.009
36. Faltado AL, Macalalad-Josue AA, Li RJS, Quisumbing JPM, Yu MGY, Jimeno CA. Factors associated with postoperative diabetes insipidus after pituitary surgery. Endocrinol Metab. 2017;32(4):426-33. https://pubmed.ncbi.nlm.nih.gov/29199401 https://pmc.ncbi.nlm.nih.gov/articles/PMC5744728 https://doi.org/10.3803/EnM.2017.32.4.426 DOI: https://doi.org/10.3803/EnM.2017.32.4.426
37. Chowdhury T, Prabhakar H, Bithal PK, Schaller B, Dash HH. Immediate postoperative complications in transsphenoidal pituitary surgery: A prospective study. Saudi J Anaesth. 2014;8(3):335-41. https://pubmed.ncbi.nlm.nih.gov/25191182 https://pmc.ncbi.nlm.nih.gov/articles/PMC4141380 https://doi.org/10.4103/1658-354X.136424 DOI: https://doi.org/10.4103/1658-354X.136424
38. Nemergut EC, Zuo Z, Jane JAJ, Laws ERJ. Predictors of diabetes insipidus after transsphenoidal surgery: A review of 881 patients. J Neurosurg. 2005;103(3):448-54. https://pubmed.ncbi.nlm.nih.gov/16235676 https://doi.org/10.3171/jns.2005.103.3.0448 DOI: https://doi.org/10.3171/jns.2005.103.3.0448
39. Horsfall HL, Lawrence A, Venkatesh A, et al. Reported outcomes in transsphenoidal surgery for pituitary adenomas: A systematic review. Pituitary. 2023;26(2):171-81. https://pubmed.ncbi.nlm.nih.gov/36862265 https://pmc.ncbi.nlm.nih.gov/articles/PMC10247847 https://doi.org/10.1007/s11102-023-01303-w DOI: https://doi.org/10.1007/s11102-023-01303-w
40. Lobatto DJ, Vliet Vlieland TPM, van den Hout WB, et al. Feasibility, safety and outcomes of a stratified fast-track care trajectory in pituitary surgery. Endocrine. 2020;69(1):175-87. https://pubmed.ncbi.nlm.nih.gov/32361869 https://pmc.ncbi.nlm.nih.gov/articles/PMC7343751 https://doi.org/10.1007/s12020-020-02308-2 DOI: https://doi.org/10.1007/s12020-020-02308-2
41. Kunigelis KE, Arnone G, Chatain G, et al. Defining the timing and role of acute postoperative imaging in pituitary adenoma surgery: Clinical study. Acta Neurochir. 2020; 162(10):2353-60. https://pubmed.ncbi.nlm.nih.gov/32779027 https://doi.org/10.1007/s00701-020-04515-2 DOI: https://doi.org/10.1007/s00701-020-04515-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mary Angeline Luz Hernandez, Denise Joy Lopez, Jian Carlo Narag, Kenny Seng, Kathleen Joy Khu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
